Elon Musk’s brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval. The FDA nod “represents an important first step that will one day allow our technology to help many people,” Neuralink said